Oral Dis:降低2型糖尿病死亡率 注意预防口腔潜在恶性疾病

2019-01-16 杨帆 中国医学论坛报今日口腔

中国台湾的一项调查研究显示,口腔潜在恶性疾病(OPMD)尤其是口腔黏膜下纤维化和红斑,在男性吸烟者和/或槟榔咀嚼者中,导致2型糖尿病患者死亡率增加,这意味着早期发现和预防口腔潜在恶性疾病不仅可以降低口腔癌死亡率,而且还可以降低2型糖尿病死亡率。该论文2018年12月27日在线发表于《口腔疾病》(Oral Dis)杂志。


中国台湾的一项调查研究显示,口腔潜在恶性疾病(OPMD)尤其是口腔黏膜下纤维化和红斑,在男性吸烟者和/或槟榔咀嚼者中,导致2型糖尿病患者死亡率增加,这意味着早期发现和预防口腔潜在恶性疾病不仅可以降低口腔癌死亡率,而且还可以降低2型糖尿病死亡率。该论文2018年12月27日在线发表于《口腔疾病》(Oral Dis)杂志。

为量化口腔潜在恶性疾病亚型对槟榔咀嚼者和/或吸烟者发生口腔癌和2型糖尿病死亡率的影响,研究者进行了回顾性队列研究,追踪了1998年~2000年期间参加社区口腔癌筛查项目的14749名男性,并一直追踪到2010年。应用Cox比例风险回归模型评价OPMD对死亡率的影响。

研究结果发现共有 1291例(8.75%)患者诊断为OPMD。在基线时未患2型糖尿病的情况下,存在口腔黏膜下纤维化[aHR为3.62,95%可信区间(CI)为1.25~10.51)]和红斑(aHR为5.01,95%CI为1.17~21.45)的2型糖尿病患者死亡风险更高。OPMD患者全因死亡风险升高的主要原因是口腔癌和2型糖尿病,而非其他死亡原因。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2020554, encodeId=0c70202055482, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Jan 26 08:44:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012916, encodeId=f978201291603, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Dec 02 21:44:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042203, encodeId=d032104220391, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Jan 17 01:44:00 CST 2019, time=2019-01-17, status=1, ipAttribution=)]
    2019-01-26 小几洁
  2. [GetPortalCommentsPageByObjectIdResponse(id=2020554, encodeId=0c70202055482, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Jan 26 08:44:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012916, encodeId=f978201291603, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Dec 02 21:44:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042203, encodeId=d032104220391, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Jan 17 01:44:00 CST 2019, time=2019-01-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2020554, encodeId=0c70202055482, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Jan 26 08:44:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012916, encodeId=f978201291603, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Dec 02 21:44:00 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042203, encodeId=d032104220391, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Jan 17 01:44:00 CST 2019, time=2019-01-17, status=1, ipAttribution=)]
    2019-01-17 misszhang

    谢谢MedSci提供最新的资讯

    0